Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphomaJennifer L. Crombie, Anupama Kalsekar, Julie Blædel et al.|Leukemia & lymphoma/Leukemia and lymphoma|2024Cited by 6
Real-world outcomes with novel therapies in R/R DLBCL.Jennifer L. Crombie, Anupama Kalsekar, Monika Jun et al.|Journal of Clinical Oncology|2023Cited by 3
REAL‐WORLD OUTCOMES WITH NOVEL THERAPIES IN R/R DLBCLJennifer L. Crombie, Anupama Kalsekar, M. Jun et al.|Hematological Oncology|2023Cited by 1
P1176: CLINICAL OUTCOMES OF NOVEL THERAPIES IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMAJennifer L. Crombie, Anupama Kalsekar, Jon Ukropec et al.|HemaSphere|2023Cited by 0